Relative risk of patients with positive CXCR4 expressing tumours but negative staining for SDF-1 was not significantly higher compared with patients with negative CXCR4 expressing tumours in the same background (relative risk of 1.57, P=0.281). This evidence concerns the gene CXCL12 and neoplasm.